H. Lundbeck A/S (HLUBF)
6.40
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
H. Lundbeck EPS Diluted (Quarterly) : 0.18 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.18 |
| March 31, 2026 | 0.2616 |
| December 31, 2025 | -0.0042 |
| September 30, 2025 | 0.1739 |
| June 30, 2025 | 0.1445 |
| March 31, 2025 | 0.1593 |
| December 31, 2024 | 0.0851 |
| September 30, 2024 | 0.1153 |
| June 30, 2024 | 0.112 |
| March 31, 2024 | 0.1476 |
| December 31, 2023 | 0.0195 |
| September 30, 2023 | 0.0994 |
| June 30, 2023 | 0.0883 |
| March 31, 2023 | 0.1277 |
| December 31, 2022 | 0.043 |
| September 30, 2022 | 0.0937 |
| June 30, 2022 | 0.0727 |
| March 31, 2022 | 0.0782 |
| December 31, 2021 | -0.0004 |
| September 30, 2021 | 0.0641 |
| June 30, 2021 | 0.0771 |
| March 31, 2021 | 0.1265 |
| December 31, 2020 | 0.1114 |
| September 30, 2020 | 0.0815 |
| June 30, 2020 | 0.0971 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0171 |
| December 31, 2019 | 0.0263 |
| September 30, 2019 | 0.1408 |
| June 30, 2019 | 0.1492 |
| March 31, 2019 | 0.1719 |
| December 31, 2018 | 0.1258 |
| September 30, 2018 | 0.207 |
| June 30, 2018 | 0.2011 |
| March 31, 2018 | 0.2488 |
| December 31, 2017 | 0.1099 |
| September 30, 2017 | 0.1744 |
| June 30, 2017 | 0.1135 |
| March 31, 2017 | 0.1064 |
| December 31, 2016 | 0.0866 |
| September 30, 2016 | 0.0607 |
| June 30, 2016 | 0.0448 |
| March 31, 2016 | 0.0347 |
| December 31, 2015 | -0.0833 |
| September 30, 2015 | -0.2383 |
| June 30, 2015 | -0.7361 |
| March 31, 2015 | -0.0155 |
| December 31, 2014 | -0.1351 |
| September 30, 2014 | 0.0013 |
| June 30, 2014 | 0.0335 |
| March 31, 2014 | 0.0776 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7362 |
| ALK-Abello A/S | 0.2377 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 178.61M |
| Revenue (Quarterly) | 1.014B |
| Total Expenses (Quarterly) | 835.63M |
| Enterprise Value | 7.454B |
| Gross Profit Margin (Quarterly) | 79.00% |
| Profit Margin (Quarterly) | 17.61% |
| Earnings Yield | 9.55% |
| Operating Earnings Yield | 17.19% |
| Normalized Earnings Yield | 11.32 |